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Abstract
Background: The aim of this study was to determine whether the diffusion tensor-derived radial diffusivity and axial
diffusivity, measured in the cortico-spinal tract in the cervical cord, predict clinical recovery after a cord relapse in
patients with multiple sclerosis, and change over time.
Methods: Fourteen patients were clinically assessed at the onset of a cervical cord relapse and after 1, 3 and 6 months.
Patients and 13 age-matched healthy controls underwent spinal cord diffusion tensor imaging at each time point. The
directional diffusivities from diffusion tensor imaging, termed radial diffusivity and axial diffusivity, were calculated in
regions of interest placed in the lateral columns, where the cortico-spinal tract is located, and in the anterior and
posterior columns. Regression analyses identified predictors of clinical outcome, adjusting for age, gender, cord cross-
sectional area and baseline clinical score, and estimated the differences in the rate of change in diffusion tensor imaging
measures between groups over time, adjusting for changes in cord cross-sectional area.
Results: Lower radial diffusivity of the cortico-spinal tract at baseline was associated with better clinical outcome. As
patients improved clinically during the follow-up, they showed greater decrease in radial diffusivity of the cortico-spinal
tract than controls.
Conclusions: The predictive role of radial diffusivity and its dynamic changes over time suggest that this index reflects
spinal cord pathological processes, including resolution of inflammation and remyelination, that contribute to clinical
recovery in multiple sclerosis. This suggests that radial diffusivity may be useful in trials that promote recovery after
spinal cord injury and could be applied to other neurological diseases affecting the spinal cord.
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Introduction
Relapses are a distinctive feature of multiple sclerosis
(MS) and are associated with new inﬂammatory
lesions on magnetic resonance imaging (MRI).
1 New
lesions in the spinal cord can cause disabling symptoms,
because important neurological functions are conveyed
within a narrow canal space. Although the majority of
patients make a clinical recovery, in some cases recovery
is only partial, leading to accumulation of disability.
Understanding the neurobiological mechanisms behind
this incomplete (and occasionally absent) clinical recov-
ery is essential in order to develop eﬀective treatments
that reduce the impact of acute injury to the spinal cord.
Here we investigated changes in the microstructure
of the cervical cord aﬀected by an acute lesion, in
patients with MS, by measuring the spinal cord direc-
tional diﬀusivities, which are derived from the diﬀusion
tensor (DT),
2 and which have the potential to reﬂect
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3–6 more accurately than stan-
dard DT imaging (DTI) indices. The directional diﬀu-
sivities are: (1) the ‘axial diﬀusivity’ (AD), which is the
principal eigenvalue of the DT, and (2) the ‘radial
diﬀusivity’ (RD), which is the average of the second
and third eigenvalues of the DT. AD is considered to
represent the water diﬀusion parallel to the main struc-
ture of the voxel, e.g. white matter ﬁbres,
7 whilst the
RD represents the water diﬀusion perpendicular to
this direction, hence to the white matter ﬁbres. In the
spinal cord of mice with experimental allergic enceph-
alomyelitis (EAE), decreased AD and increased RD
are markers of axonal damage and demyelination,
respectively.
8,9
In a previous study in which we examined the
directional diﬀusivities in the spinal cord of patients
with MS at the onset of a relapse due to a lesion at
C1–C3,
10 we found that the RD of the lateral cortico-
spinal tract (CST) essentially drove the observed
changes in fractional anisotropy (FA), which is a stan-
dard DTI-derived index obtained by combining the
three eigenvalues of the DT; RD also showed a stronger
correlation with acute disability than did FA. However,
a recent DTI study of the optic nerve found that AD
decreased acutely after optic neuritis, and was reported
to be a useful predictor of vision.
11
Therefore, in order to determine whether AD and
RD at the onset of an acute event predict subsequent
clinical recovery, we carried out a prospective longitu-
dinal study in the same cohort of MS patients, and
employed spinal cord DTI and a region-of-interest
(ROI) analysis. In particular, we tested two hypotheses:
(1) RD and AD of the CST in the lateral columns
predict clinical recovery; and (2) RD and AD of the
CST change over time in patients when compared
with controls. To complete the analysis, we also inves-
tigated the standard diﬀusion indices, such as FA, and
measured the directional diﬀusivities and the standard
DTI indices in the anterior and posterior spinal cord
columns.
Methods
Subjects
We recruited patients who attended the Outpatient
Clinic at the National Hospital for Neurology and
Neurosurgery (NHNN) and fulﬁlled the following
inclusion criteria: (1) a diagnosis of MS;
12 (2) acute
development of motor signs, which were judged to be
due to a lesion at C1–C3; (3) onset within 4 weeks of
visit; and (4) presence of at least one lesion in the
spine between C1 and C3 documented by conventional
imaging. Due to radiological characteristics and
clinical signs, despite the absence of contrast-enhanced
imaging, these cervical lesions were considered to be
very likely acute, as previously explained.
10
Patients were invited to attend follow-up visits at 1, 3
and 6 months. At each visit, patients underwent MRI
scans, and were clinically assessed on the Expanded
Disability Status Scale (EDSS),
13 9-Hole Peg Test
(9HPT),
14 Timed 25-foot Walk Test (TWT),
15 and
Multiple Sclerosis Walking Scale-12 (MSWS-12).
16
The average of two trials for each hand of the 9HPT
and the inverse of the mean of two trials for the TWT
(iTWT) were calculated.
17
Age- and gender-matched healthy subjects were
recruited at baseline and invited to attend MRI scans
at the same time points.
All subjects gave informed, written consent before
the study, which was approved by the Joint Ethics
Committee of the Institute of Neurology and the
NHNN.
MRI protocol and processing
MRI of the cervical cord was performed on a
1.5T GE scanner (maximum gradient amplitude¼
33 10
 3Tm
 1). At each time point, all subjects were
repositioned in the scanner in a consistent way by the
radiographer and underwent the following spinal cord
sequences:
(i) T2 and PD-weighted imaging (TR 3300ms/TE
110ms and TR3000ms/TE 8.9ms, echo train
length 33 and 11, FOV 240 240mm
2, matrix
256 224, interpolated to 512 512, 12 contiguous
sagittal- and coronal-oblique slices, 3mm slice
thickness), which was used to conﬁrm the pres-
ence of the lesion at C1–C3 and screen for cord
swelling (as deﬁned in Ciccarelli et al.
10) at each
time point.
(ii) Cardiac gated CO-ZOOM-EPI (contiguous zonally
orthogonal multislice echo-planar imaging)
18 (TE
96ms, TR&15 RR, six non-diﬀusion-weighted
images, diﬀusion gradients applied along 60 opti-
mized diﬀusion weighting directions,
19 maximum
b-factor of 1000s/mm
2, FOV 70 47mm
2, matrix
48 32, reconstructed to 1 1mm
2, 30 contiguous
axial slices, 5mm slice thickness).
(iii) Volume-acquired, inversion-prepared, fast-spoiled-
gradient recalled (FSPGR) imaging (TR 13.2ms,
TE4.2ms, TI450ms, ﬂip angle 20 , FOV
250 250mm
2, matrix 256 256, 60 contiguous
sagittal slices, 1mm slice thickness), which was
used to calculate the cross-sectional cord area at
C2–C3 using a semi-automated technique
20 at
each time point.
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analysis
The DT data were screened manually for slices
aﬀected by artefacts, which were marked for exclusion
from the tensor ﬁtting. An anisotropic diﬀusion ﬁlter
was applied to the DTI data to reduce image noise.
21
RD, AD, FA (which reﬂects the directionality of the
underlying tissue structures), and mean diﬀusivity
(MD) (which reﬂects the amount of water diﬀusion
regardless of its preferential directionality) maps
were obtained from the DT estimated with the
RESTORE algorithm (robust estimation of diﬀusion
tensor with outlier rejection
22), using Camino soft-
ware.
22,23 A condition for the use of RESTORE is
that the percentage of excluded artifactual data
points is low ( 6.67%).
22 Therefore, datasets with
 6% (or  4) diﬀusion-weighted volumes aﬀected by
artefacts were excluded from the analysis. The direc-
tionality of the principal eigenvalue compared with the
spinal cord anatomical structures was visually checked
in each subject at each time point.
In each subject, at each time point, four ROIs were
placed on each non-diﬀusion-weighted b0 image
between C1 to C3. They were located in the posterior
part of the lateral columns, where the lateral CST is
known to run through (ROI size¼4voxels (24mm
3)),
and in the anterior and posterior columns (ROI
size¼6voxels (36mm
3)) (Figure 1). As it is impossible
to distinguish lesions from normal tissue on the b0
maps, these ROIs probably encompassed not only the
focal lesions, but also the non-lesional white matter.
The ROIs were copied directly onto the derived RD,
AD, FA, and MD maps (Figure 1). The mean value of
each diﬀusion parameter within each ROI was calcu-
lated. To obtain the intra-observer coeﬃcient-of-varia-
tion (CV¼(SD/mean) 100) for the DTI indices in
each ROI, a second experiment was run by the same
observer (PF), who was blind to the results of the ﬁrst
experiment, 3 months later, on three patients and three
controls randomly chosen. The mean CV of the diﬀu-
sion indices of all ROIs was 2.7% (Supplementary
Table 1).
Statistical analysis
Changes in clinical scores over the follow-up
period. To assess whether patients’ clinical scores
changed signiﬁcantly from baseline to 6 months, the
paired sample t-test was used (after checking the
normal distribution of the scores).
Differences in diffusion indices between patients and
controls at each time point. At each time point, to
investigate the diﬀerences in each diﬀusion index of
each ROI between patients and controls, the two-
sample t-test was used.
Baseline predictors of outcome. To identify indepen-
dent predictors of clinical changes in patients, a
multiple linear regression model was used. ITWT,
9HPT, MSWS-12 at 6 months were used, in turn, as
dependent variable. The baseline diﬀusion indices were
used as covariates, together with the corresponding
baseline clinical score, age, gender, and baseline cord
cross-sectional area.
For the analysis of the EDSS, an ordinal logistic
multiple regression model was used, entering an indica-
tor of the clinical outcome, deﬁned on the basis of the
FA MD
RD BO AD
Figure 1. Axialimages(B0,RD,AD,FA,MD)ofthecervicalspinal
cordshowingthelocationofregionsofinterest(ROIs)placedinthe
anterior,lateralandposteriorcolumns ofthespinalcord.Notethat
ROI were first drawn on the B0 images and then overlaid onto the
diffusion maps. (A¼anterior, P¼posterior, L¼left, R¼right).
AD, axial diffusivity; FA, fractional anisotropy; MD, mean diffusivity;
RD, radial diffusivity.
Table 1. Clinical scores at baseline and 6 months follow-up
Baseline 6 months p-value*
EDSS Median 4
(range 2.5, 6.5)
Median 3.5
(range 1, 6.5)
0.005
TWT (s) Mean 9
(SD 3.2)
Mean 7
(SD 1.2)
<0.0001
MSWS-12 Mean 47
(SD 7)
Mean 33
(SD 13)
<0.0002
9HPT (s) Mean 36.8
(SD 37.6)
Mean 23.02
(SD 3.31)
0.184
*paired t-test.
EDSS, Expanded Disability Status Scale; MSWS-12, Multiple Sclerosis
Walking Scale-12; TWT, Timed 25-foot Walk Test; 9HPT, 9-Hole
Peg Test.
Freund et al. 1195EDSS changes, as response variable (i.e. the ‘presence
of clinical improvement’ was deﬁned as a reduction in
the EDSS between 6 months and baseline   0.5, and
the ‘absence of recovery’ was deﬁned as the lack of any
EDSS change). The baseline diﬀusion indices were used
as covariates, together with baseline EDSS, age, gender,
and baseline cord cross-sectional area. Using mixed-
eﬀect linear regression models, we also investigated
whether the diﬀusion measures at baseline diﬀered
between patients who improved and patients who did
not recover, using the diﬀusion index as response var-
iable, and entering an indicator for these two groups of
patients, and all the variables listed above, as covari-
ates. For all these regression models, the mean values of
the diﬀusion indices of the left and right CST-ROI were
used, since there were no signiﬁcant diﬀerences in any
baseline DTI parameter between the left and right side
in patients and controls (using the Wilcoxon-Signed
Rank test).
Longitudinal analysis: Estimation of the rate of
change in the diffusion indices over time. Mixed-
eﬀect linear regression models were used to estimate
the rate of change in the DTI indices over time, adjust-
ing for age and changes in cord cross-sectional area,
which has been shown to decrease over time in this
patient cohort.
24 In particular, after conﬁrming that
time delay from onset of symptoms to baseline MRI
did not inﬂuence the diﬀusion measures at study
entry, each DTI measure of each ROI was used, in
turn, as response variable, with time as predictor.
A subject-type indicator and type time interaction
term were used to estimate the diﬀerence in the rate
of changes between patients and controls, and to
assess the rate of changes in controls. These models
allow for missing time points, and maximize eﬃcient
use of the available data.
Stata 9.2 (www.stata.com) was used. Results associ-
ated with p<0.05 are reported.
Results
Subjects
Fourteen MS patients were recruited at baseline (mean
age 35.3 years (SD 8.16), nine women, 13 patients with
relapsing-remitting and one with secondary-progressive
MS). One patient did not undergo any follow-up scan,
but was clinically assessed at 6 months; one patient did
not attend his 1-month follow-up visit, and the DTI
was not acquired in one patient at 1-month follow-
up, due to technical problems with the scanner.
Details relating to patient symptoms and conventional
MRI characteristics, including T2 lesions and cord
swelling at baseline and at 6 months, have been
reported previously;
10 baseline cervical cord swelling
resolved within a month in all cases except one.
All 13 age- and gender-matched controls (mean age
40.9 years (SD12.6), eight women; two-sample t-test
(controls vs. patients) p¼0.21) studied at baseline
attended their follow-up scans.
Changes in clinical scores over the follow-up period
Patients improved over time, as reﬂected in changes in
their EDSS, iTWT and MSWS-12 scores (Table 1).
Nine patients improved on the EDSS and ﬁve patients
did not.
Differences in diffusion indices between patients and
controls at each time point
A total of 24, 20, 19 and 21 datasets at baseline, 1, 3
and 6 months, respectively, were included in the ﬁnal
analysis. Patients showed higher RD in the right and
left CST-ROI at baseline, in the right CST-ROI at
6 months, and in the anterior and posterior columns
at all time points; AD in the posterior columns diﬀered
between patients and controls at three months (Table 2).
Turning to the standard diﬀusion indices, patients
had lower FA than controls in the right and left CST-
ROI at baseline, in the right CST-ROI at 6 months, and
in the anterior and posterior columns at all time points.
MD in the posterior columns was signiﬁcantly higher in
patients than in controls at 1 and 3 months, whereas
MD in the anterior columns was higher in patients than
controls at baseline, 1 and 3 months (Table 2).
Baseline predictors of recovery
Lower RD of the mean of the left and right CST-ROI
at baseline predicted better outcome; in particular,
baseline RD was associated with iTWT (coeﬀ.
 1.48 10
 4, p¼0.026, 95% conﬁdence interval (CI)
 2.73 10
 4, 2.2 10
 5) and 9HPT (coeﬀ. 0.02,
p¼0.041, 95% CI 0.001, 0.04) at 6 months, and
showed a borderline association with MSWS-12
(coeﬀ. 0.06, p¼0.07; 95% CI  0.006, 0.12) at 6
months (Figure 2).
When we examined the standard diﬀusion indices,
we found that higher FA of the mean lateral CST-
ROI also predicted better outcome; in particular, base-
line FA was associated with iTWT (coeﬀ. 2.2 10
 5,
p¼0.014, 95% CI 6 10
 6, 3.8 10
 5), 9HPT (coeﬀ.
 2.84 10
 3, p¼0.032, 95% CI  5.38 10
 3,
 3.03 10
 4) and MSWS-12 (coeﬀ.  8.69 10
 3,
p¼0.045, 95% CI  0.02,  2.18 10
 4) at 6 months
(Figure 2).
Patients who improved on the EDSS showed a sig-
niﬁcantly lower RD of the mean lateral CST-ROI at
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Figure 2. Graphs showing the correlations between the diffusion indices at baseline and clinical score at 6 months: (A) RD of the
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1198 Multiple Sclerosis 16(10)baseline, and a signiﬁcantly higher FA of the same
tract at baseline, when compared with patients who
did not recover (RD of the CST-ROI: patients who
improved/patients who did not recover, diﬀerence
 0.13, p¼0.018, 95% CI  0.24,  0.02; FA of the
CST-ROI: 0.09, p¼0.016, 95% CI 0.02, 0.16).
Longitudinal analysis: estimation of the rate of
change in the diffusion indices over time
Patients showed a greater decline in the RD of the
left CST-ROI over the follow-up period when
compared with controls (by 0.016mm
2/s 10
 3 per
month, p¼0.049, 95% CI 6 10
 5, 0.031), adjusting
for changes in cord cross-sectional area over time
(Figure 3). The rate of change in AD of this tract did
not signiﬁcantly diﬀer between patients and controls
(by 0.011mm
2/s 10
 3 per month, p¼0.382, 95% CI
 0.036, 0.013).
Turning to the conventional diﬀusion indices,
patients showed a greater increase in the FA of the
left lateral CST-ROI compared with controls over
time (by 0.01mm
2/s 10
 3 per month, p¼0.027, 95%
CI 0.24, 0.01). The rate of change in MD of this tract
did not diﬀer between groups (by 0.007mm
2/s 10
 3
per month, p¼0.393, 95% CI  0.01, 0.025).
In controls, no diﬀusion index in any region changed
over time.
Discussion
Animal studies have demonstrated (i) the potential of
the directional diﬀusivities to provide information on
the pathological processes in addition to that derived
from the conventional diﬀusion indices,
3–6,8,9,25–27 and
(ii) their sensitivity to pathological changes in the spinal
cord at the site of the focal lesions and in locations
distal to them.
28 Our study in patients with MS after
an upper cervical cord relapse suggests that RD is sen-
sitive to tissue microstructural changes that inﬂuence
clinical recovery and are dynamic over time. In partic-
ular, we found that the RD of the CST-ROI, which
encompassed the lesional and non-lesional tissues, pre-
dicted a better clinical outcome after 6 months, and
signiﬁcantly decreased over time. These results were
signiﬁcant after correcting for cord cross-sectional
area which, in the acute phase, is an indirect measure
of the amount of oedema related to acute inﬂammation
(i.e. cord swelling), while in the chronic phase is a
marker of cord axonal loss.
29
From a pathophysiological perspective, several
mechanisms may contribute to tissue repair and conse-
quent clinical improvement. In a previous study carried
out in the same patient population, we proposed that
increased mitochondrial metabolism contributes to
clinical recovery.
24 In addition to this repair mecha-
nism, resolution of inﬂammation and remyelination
also occur. Remyelination, in particular, leads to the
restoration of myelin sheaths on demyelinated axons
which, in turn, re-establishes saltatory conduction and
resolves symptoms of acute relapse.
30 Although linking
RD to myelin integrity in the spinal cord of these
patients is tempting, especially considering the exten-
sive body of evidence from animal studies,
5 it is likely
to be an oversimpliﬁcation of the underlying tissue
changes. Indeed, robust RD changes can be seen in
the absence of any myelin loss,
6 and in vivo brain stud-
ies in patients with MS have suggested that the radial
component of the DT does not selectively measure
demyelination.
31 Further imaging studies, which will
combine diﬀerent indices sensitive to myelin and
axonal integrity, together with histological ﬁndings,
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Figure 3. Mean values (and SDs) of the radial diffusivity (A) and fractional anisotropy (B) of the left cortico-spinal tract (lCST) in MS
patients (in green) and controls (in blue) at baseline, 1 month, 3 months and 6 months.
Freund et al. 1199should conﬁrm the relative speciﬁcity of the AD and
RD to acute and chronic demyelination and axonal loss
in the human spinal cord.
From a technical point of view, we chose an ROI
approach in order to be conﬁdent that the ROIs are
positioned in the columns that contain ascending and
descending tracts. In these regions, the directional diﬀu-
sivities reﬂect the underlying structural characteristics.
32
An alternative methodological approach would be to
employ diﬀusion-based tractography, as reported in
our previous publications in MS
10 and in other neuro-
logical disorders.
33 However, in humans, the exact cor-
respondence between the reconstructed tracts and the
real pathways cannot be conﬁrmed as convincingly as
in animals,
28 and ROIs need to be used in order to seed
the tracts. In addition, since the diﬀusion parameters in
the left CST tends to have greater FA values than the
right CST in healthy subjects,
34 and MS pathology may
be asymmetric in the spinal cord, we kept the division
between the left and right CST in the analysis of the
comparisons between patients and control.
Moreover, we could not investigate the association
between lesion location and the diﬀusion indices
because it was diﬃcult to locate the lesions on the
basis of the sole sagittal images, and the diﬀerentiation
of lesional tissue from the normal-appearing white
matter was not possible on the diﬀusion maps.
The results relating to AD were negative, suggesting
that this index may be less sensitive than RD in detect-
ing spinal cord pathological changes occurring in the
spinal cord after acute lesions. Conversely, a recent
DTI study proposed AD as a marker of acute axonal
injury,
27 and another study in patients with optic neu-
ritis reported that this index was associated with tests of
vision after 1 and 3 months.
11 However, the same
authors found that RD, in contrast to AD, showed
the highest correlations with clinical tests when patients
with well-established disease were studied.
11 Their
hypothesis was that in the presence of extensive demy-
elination, AD may lose its sensitivity to reﬂect axonal
integrity. However, in an animal model of EAE, AD
was found to correlate with acute axonal injury.
27
We cannot exclude that a constant AD is still compat-
ible with axonal loss, if the larger diameter ﬁbres are
preserved and the ﬁbres of small diameter of the CST
are preferentially lost.
35 However, the interpretation of
AD and RD in relation to pathological changes and
observations in animal studies is likely to be an over-
simpliﬁcation in respect to what is happening in MS,
where complex tissue changes are occurring; for exam-
ple, both increased
36 and reduced AD
11,31 has been
described in MS and optic neuritis patients when com-
pared with controls.
The behaviour of the diﬀusion indices varied accord-
ing to the regions investigated. For example, the FA
and RD of the lateral CST-ROI diﬀered between
patients and controls at baseline (also when adjusting
for delay from symptom onset, results not shown), but
then normalized over time, whilst the same diﬀusion
measures in the anterior and posterior columns were
abnormal in patients at all time points. This could be
explained by the speciﬁc location of the lesion in the
spinal cord. Unfortunately, we could not investigate the
association between lesion location (anterior, posterior,
lateral, for example) and the diﬀusion indices, because
the diﬀerentiation of lesional tissue from the normal-
appearing white matter was not possible on the diﬀusion
maps. However, all the lesions responsible for clinical
signs were within the ROIs studied. Studies using high-
resolution spinal cord imaging will assess the contribu-
tion of the lesion and that of the surrounding and
connected white matter in determining clinical changes.
In conclusion, the RD of the CST-ROI in the region
of the cord aﬀected by an acute lesion predicts clinical
outcome after a spinal cord relapse and reﬂects the
dynamic pathological changes that inﬂuence recovery.
Future studies will investigate whether the role of AD
as predictor of outcome becomes more relevant in con-
ditions which are characterized by predominant axonal
degeneration. Thus, RD is an informative measure
which may become useful in clinical trials that promote
recovery after spinal cord acute lesions, once accurate
standardization of protocol acquisition, including a spe-
ciﬁc b-value and pre-determined number of diﬀusion
gradients directions and tensor ﬁtting, is performed.
37
InvestigationsofspinalcordRDdeservestobeextended
to other neurological diseases aﬀecting the spinal cord.
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